▶ 調査レポート

分子インフルエンザ検査の世界市場2020年:企業別、地域別、種類・用途別

• 英文タイトル:Global Molecular Influenza Test Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。分子インフルエンザ検査の世界市場2020年:企業別、地域別、種類・用途別 / Global Molecular Influenza Test Market 2020 by Company, Regions, Type and Application, Forecast to 2025 / D0GIR-03011資料のイメージです。• レポートコード:D0GIR-03011
• 出版社/出版日:GlobalInfoResearch / 2020年9月30日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、103ページ
• 納品方法:Eメール
• 産業分類:医療、製薬、バイオ
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、分子インフルエンザ検査の世界市場を広く調査・分析し、今後の市場展望をまとめております。分子インフルエンザ検査の種類別市場規模(RT-PCR、TMA、LAMP、NASBA、その他)、用途別市場規模(病院、臨床検査室、その他のエンドユーザー)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):F. Hoffmann-La Roche、Abbott Laboratories、Quidel Corporation、bioMérieux、Thermo Fisher Scientific、DiaSorin、Becton, Dickinson, and Company
・地域別グローバル市場分析 2015年-2020年
・分子インフルエンザ検査の北米市場(アメリカ、カナダ、メキシコ)
・分子インフルエンザ検査のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・分子インフルエンザ検査のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・分子インフルエンザ検査の南米市場(ブラジル、アルゼンチン)
・分子インフルエンザ検査の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:RT-PCR、TMA、LAMP、NASBA、その他
・用途別分析:病院、臨床検査室、その他のエンドユーザー
・地域別市場規模予測 2021年-2025年
・調査の結果・結論

Market Overview
The Molecular Influenza Test market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Molecular Influenza Test market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

Market segmentation
Molecular Influenza Test market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Molecular Influenza Test market has been segmented into:
RT-PCR
TMA
LAMP
NASBA
Other

By Application, Molecular Influenza Test has been segmented into:
Hospitals
Clinical Laboratories
Other End-User

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Molecular Influenza Test market presented in the report. This section sheds light on the sales growth of different regional and country-level Molecular Influenza Test markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Molecular Influenza Test market.

The report offers in-depth assessment of the growth and other aspects of the Molecular Influenza Test market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Molecular Influenza Test Market Share Analysis
Molecular Influenza Test competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Molecular Influenza Test sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Molecular Influenza Test sales, revenue and market share for each player covered in this report.

The major players covered in Molecular Influenza Test are:
F. Hoffmann-La Roche
Abbott Laboratories
Quidel Corporation
bioMérieux
Thermo Fisher Scientific
DiaSorin
Becton, Dickinson, and Company
Among other players domestic and global, Molecular Influenza Test market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

レポート目次

1 Molecular Influenza Test Market Overview
1.1 Product Overview and Scope of Molecular Influenza Test
1.2 Classification of Molecular Influenza Test by Type
1.2.1 Global Molecular Influenza Test Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Molecular Influenza Test Revenue Market Share by Type in 2019
1.2.3 RT-PCR
1.2.4 TMA
1.2.5 LAMP
1.2.6 NASBA
1.2.7 Other
1.3 Global Molecular Influenza Test Market by Application
1.3.1 Overview: Global Molecular Influenza Test Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinical Laboratories
1.3.4 Other End-User
1.4 Global Molecular Influenza Test Market by Regions
1.4.1 Global Molecular Influenza Test Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Molecular Influenza Test (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Molecular Influenza Test Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Molecular Influenza Test Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Molecular Influenza Test Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Molecular Influenza Test Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Molecular Influenza Test Status and Prospect (2015-2025)
2 Company Profiles
2.1 F. Hoffmann-La Roche
2.1.1 F. Hoffmann-La Roche Details
2.1.2 F. Hoffmann-La Roche Major Business
2.1.3 F. Hoffmann-La Roche SWOT Analysis
2.1.4 F. Hoffmann-La Roche Product and Services
2.1.5 F. Hoffmann-La Roche Molecular Influenza Test Revenue, Gross Margin and Market Share (2018-2019)
2.2 Abbott Laboratories
2.2.1 Abbott Laboratories Details
2.2.2 Abbott Laboratories Major Business
2.2.3 Abbott Laboratories SWOT Analysis
2.2.4 Abbott Laboratories Product and Services
2.2.5 Abbott Laboratories Molecular Influenza Test Revenue, Gross Margin and Market Share (2018-2019)
2.3 Quidel Corporation
2.3.1 Quidel Corporation Details
2.3.2 Quidel Corporation Major Business
2.3.3 Quidel Corporation SWOT Analysis
2.3.4 Quidel Corporation Product and Services
2.3.5 Quidel Corporation Molecular Influenza Test Revenue, Gross Margin and Market Share (2018-2019)
2.4 bioMérieux
2.4.1 bioMérieux Details
2.4.2 bioMérieux Major Business
2.4.3 bioMérieux SWOT Analysis
2.4.4 bioMérieux Product and Services
2.4.5 bioMérieux Molecular Influenza Test Revenue, Gross Margin and Market Share (2018-2019)
2.5 Thermo Fisher Scientific
2.5.1 Thermo Fisher Scientific Details
2.5.2 Thermo Fisher Scientific Major Business
2.5.3 Thermo Fisher Scientific SWOT Analysis
2.5.4 Thermo Fisher Scientific Product and Services
2.5.5 Thermo Fisher Scientific Molecular Influenza Test Revenue, Gross Margin and Market Share (2018-2019)
2.6 DiaSorin
2.6.1 DiaSorin Details
2.6.2 DiaSorin Major Business
2.6.3 DiaSorin Product and Services
2.6.4 DiaSorin Molecular Influenza Test Revenue, Gross Margin and Market Share (2018-2019)
2.7 Becton, Dickinson, and Company
2.7.1 Becton, Dickinson, and Company Details
2.7.2 Becton, Dickinson, and Company Major Business
2.7.3 Becton, Dickinson, and Company Product and Services
2.7.4 Becton, Dickinson, and Company Molecular Influenza Test Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Molecular Influenza Test Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Molecular Influenza Test Players Market Share
3.2.2 Top 10 Molecular Influenza Test Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Molecular Influenza Test Revenue and Market Share by Regions
4.2 North America Molecular Influenza Test Revenue and Growth Rate (2015-2020)
4.3 Europe Molecular Influenza Test Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Molecular Influenza Test Revenue and Growth Rate (2015-2020)
4.5 South America Molecular Influenza Test Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Molecular Influenza Test Revenue and Growth Rate (2015-2020)
5 North America Molecular Influenza Test Revenue by Countries
5.1 North America Molecular Influenza Test Revenue by Countries (2015-2020)
5.2 USA Molecular Influenza Test Revenue and Growth Rate (2015-2020)
5.3 Canada Molecular Influenza Test Revenue and Growth Rate (2015-2020)
5.4 Mexico Molecular Influenza Test Revenue and Growth Rate (2015-2020)
6 Europe Molecular Influenza Test Revenue by Countries
6.1 Europe Molecular Influenza Test Revenue by Countries (2015-2020)
6.2 Germany Molecular Influenza Test Revenue and Growth Rate (2015-2020)
6.3 UK Molecular Influenza Test Revenue and Growth Rate (2015-2020)
6.4 France Molecular Influenza Test Revenue and Growth Rate (2015-2020)
6.5 Russia Molecular Influenza Test Revenue and Growth Rate (2015-2020)
6.6 Italy Molecular Influenza Test Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Molecular Influenza Test Revenue by Countries
7.1 Asia-Pacific Molecular Influenza Test Revenue by Countries (2015-2020)
7.2 China Molecular Influenza Test Revenue and Growth Rate (2015-2020)
7.3 Japan Molecular Influenza Test Revenue and Growth Rate (2015-2020)
7.4 Korea Molecular Influenza Test Revenue and Growth Rate (2015-2020)
7.5 India Molecular Influenza Test Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Molecular Influenza Test Revenue and Growth Rate (2015-2020)
8 South America Molecular Influenza Test Revenue by Countries
8.1 South America Molecular Influenza Test Revenue by Countries (2015-2020)
8.2 Brazil Molecular Influenza Test Revenue and Growth Rate (2015-2020)
8.3 Argentina Molecular Influenza Test Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Molecular Influenza Test by Countries
9.1 Middle East & Africa Molecular Influenza Test Revenue by Countries (2015-2020)
9.2 Saudi Arabia Molecular Influenza Test Revenue and Growth Rate (2015-2020)
9.3 UAE Molecular Influenza Test Revenue and Growth Rate (2015-2020)
9.4 Egypt Molecular Influenza Test Revenue and Growth Rate (2015-2020)
9.5 South Africa Molecular Influenza Test Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Molecular Influenza Test Revenue and Market Share by Type (2015-2020)
10.2 Global Molecular Influenza Test Market Forecast by Type (2019-2024)
10.3 RT-PCR Revenue Growth Rate (2015-2025)
10.4 TMA Revenue Growth Rate (2015-2025)
10.5 LAMP Revenue Growth Rate (2015-2025)
10.6 NASBA Revenue Growth Rate (2015-2025)
10.7 Other Revenue Growth Rate (2015-2025)
11 Global Molecular Influenza Test Market Segment by Application
11.1 Global Molecular Influenza Test Revenue Market Share by Application (2015-2020)
11.2 Molecular Influenza Test Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinical Laboratories Revenue Growth (2015-2020)
11.5 Other End-User Revenue Growth (2015-2020)
12 Global Molecular Influenza Test Market Size Forecast (2021-2025)
12.1 Global Molecular Influenza Test Market Size Forecast (2021-2025)
12.2 Global Molecular Influenza Test Market Forecast by Regions (2021-2025)
12.3 North America Molecular Influenza Test Revenue Market Forecast (2021-2025)
12.4 Europe Molecular Influenza Test Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Molecular Influenza Test Revenue Market Forecast (2021-2025)
12.6 South America Molecular Influenza Test Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Molecular Influenza Test Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Molecular Influenza Test Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Molecular Influenza Test by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Molecular Influenza Test Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Molecular Influenza Test Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Molecular Influenza Test Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. F. Hoffmann-La Roche Corporate Information, Location and Competitors
Table 7. F. Hoffmann-La Roche Molecular Influenza Test Major Business
Table 8. F. Hoffmann-La Roche Molecular Influenza Test Total Revenue (USD Million) (2017-2018)
Table 9. F. Hoffmann-La Roche SWOT Analysis
Table 10. F. Hoffmann-La Roche Molecular Influenza Test Product and Solutions
Table 11. F. Hoffmann-La Roche Molecular Influenza Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Abbott Laboratories Corporate Information, Location and Competitors
Table 13. Abbott Laboratories Molecular Influenza Test Major Business
Table 14. Abbott Laboratories Molecular Influenza Test Total Revenue (USD Million) (2018-2019)
Table 15. Abbott Laboratories SWOT Analysis
Table 16. Abbott Laboratories Molecular Influenza Test Product and Solutions
Table 17. Abbott Laboratories Molecular Influenza Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Quidel Corporation Corporate Information, Location and Competitors
Table 19. Quidel Corporation Molecular Influenza Test Major Business
Table 20. Quidel Corporation Molecular Influenza Test Total Revenue (USD Million) (2017-2018)
Table 21. Quidel Corporation SWOT Analysis
Table 22. Quidel Corporation Molecular Influenza Test Product and Solutions
Table 23. Quidel Corporation Molecular Influenza Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. bioMérieux Corporate Information, Location and Competitors
Table 25. bioMérieux Molecular Influenza Test Major Business
Table 26. bioMérieux Molecular Influenza Test Total Revenue (USD Million) (2017-2018)
Table 27. bioMérieux SWOT Analysis
Table 28. bioMérieux Molecular Influenza Test Product and Solutions
Table 29. bioMérieux Molecular Influenza Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 31. Thermo Fisher Scientific Molecular Influenza Test Major Business
Table 32. Thermo Fisher Scientific Molecular Influenza Test Total Revenue (USD Million) (2017-2018)
Table 33. Thermo Fisher Scientific SWOT Analysis
Table 34. Thermo Fisher Scientific Molecular Influenza Test Product and Solutions
Table 35. Thermo Fisher Scientific Molecular Influenza Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. DiaSorin Corporate Information, Location and Competitors
Table 37. DiaSorin Molecular Influenza Test Major Business
Table 38. DiaSorin Molecular Influenza Test Total Revenue (USD Million) (2017-2018)
Table 39. DiaSorin SWOT Analysis
Table 40. DiaSorin Molecular Influenza Test Product and Solutions
Table 41. DiaSorin Molecular Influenza Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Becton, Dickinson, and Company Corporate Information, Location and Competitors
Table 43. Becton, Dickinson, and Company Molecular Influenza Test Major Business
Table 44. Becton, Dickinson, and Company Molecular Influenza Test Total Revenue (USD Million) (2017-2018)
Table 45. Becton, Dickinson, and Company SWOT Analysis
Table 46. Becton, Dickinson, and Company Molecular Influenza Test Product and Solutions
Table 47. Becton, Dickinson, and Company Molecular Influenza Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Global Molecular Influenza Test Revenue (Million USD) by Players (2015-2020)
Table 49. Global Molecular Influenza Test Revenue Share by Players (2015-2020)
Table 50. Global Molecular Influenza Test Revenue (Million USD) by Regions (2015-2020)
Table 51. Global Molecular Influenza Test Revenue Market Share by Regions (2015-2020)
Table 52. North America Molecular Influenza Test Revenue by Countries (2015-2020)
Table 53. North America Molecular Influenza Test Revenue Market Share by Countries (2015-2020)
Table 54. Europe Molecular Influenza Test Revenue (Million USD) by Countries (2015-2020)
Table 55. Asia-Pacific Molecular Influenza Test Revenue (Million USD) by Countries (2015-2020)
Table 56. South America Molecular Influenza Test Revenue by Countries (2015-2020)
Table 57. South America Molecular Influenza Test Revenue Market Share by Countries (2015-2020)
Table 58. Middle East and Africa Molecular Influenza Test Revenue (Million USD) by Countries (2015-2020)
Table 59. Middle East and Africa Molecular Influenza Test Revenue Market Share by Countries (2015-2020)
Table 60. Global Molecular Influenza Test Revenue (Million USD) by Type (2015-2020)
Table 61. Global Molecular Influenza Test Revenue Share by Type (2015-2020)
Table 62. Global Molecular Influenza Test Revenue Forecast by Type (2021-2025)
Table 63. Global Molecular Influenza Test Revenue by Application (2015-2020)
Table 64. Global Molecular Influenza Test Revenue Share by Application (2015-2020)
Table 65. Global Molecular Influenza Test Revenue Forecast by Application (2021-2025)
Table 66. Global Molecular Influenza Test Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Molecular Influenza Test Picture
Figure 2. Global Molecular Influenza Test Revenue Market Share by Type in 2019
Figure 3. RT-PCR Picture
Figure 4. TMA Picture
Figure 5. LAMP Picture
Figure 6. NASBA Picture
Figure 7. Other Picture
Figure 8. Molecular Influenza Test Revenue Market Share by Application in 2019
Figure 9. Hospitals Picture
Figure 10. Clinical Laboratories Picture
Figure 11. Other End-User Picture
Figure 12. Global Molecular Influenza Test Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Molecular Influenza Test Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Molecular Influenza Test Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Molecular Influenza Test Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Molecular Influenza Test Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Molecular Influenza Test Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Molecular Influenza Test Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Molecular Influenza Test Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Molecular Influenza Test Revenue Market Share in 2019
Figure 21. Global Top 10 Players Molecular Influenza Test Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Molecular Influenza Test Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Molecular Influenza Test Revenue Market Share by Regions (2015-2020)
Figure 25. Global Molecular Influenza Test Revenue Market Share by Regions in 2018
Figure 26. North America Molecular Influenza Test Revenue and Growth Rate (2015-2020)
Figure 27. Europe Molecular Influenza Test Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Molecular Influenza Test Revenue and Growth Rate (2015-2020)
Figure 29. South America Molecular Influenza Test Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Molecular Influenza Test Revenue and Growth Rate (2015-2020)
Figure 31. North America Molecular Influenza Test Revenue Market Share by Countries (2015-2020)
Figure 32. North America Molecular Influenza Test Revenue Market Share by Countries in 2019
Figure 33. USA Molecular Influenza Test Revenue and Growth Rate (2015-2020)
Figure 34. Canada Molecular Influenza Test Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Molecular Influenza Test Revenue and Growth Rate (2015-2020)
Figure 36. Europe Molecular Influenza Test Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Molecular Influenza Test Revenue Market Share by Countries in 2019
Figure 38. Germany Molecular Influenza Test Revenue and Growth Rate (2015-2020)
Figure 39. UK Molecular Influenza Test Revenue and Growth Rate (2015-2020)
Figure 40. France Molecular Influenza Test Revenue and Growth Rate (2015-2020)
Figure 41. Russia Molecular Influenza Test Revenue and Growth Rate (2015-2020)
Figure 42. Italy Molecular Influenza Test Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Molecular Influenza Test Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Molecular Influenza Test Revenue Market Share by Countries in 2019
Figure 45. China Molecular Influenza Test Revenue and Growth Rate (2015-2020)
Figure 46. Japan Molecular Influenza Test Revenue and Growth Rate (2015-2020)
Figure 47. Korea Molecular Influenza Test Revenue and Growth Rate (2015-2020)
Figure 48. India Molecular Influenza Test Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Molecular Influenza Test Revenue and Growth Rate (2015-2020)
Figure 50. South America Molecular Influenza Test Revenue Market Share by Countries (2015-2020)
Figure 51. South America Molecular Influenza Test Revenue Market Share by Countries in 2019
Figure 52. Brazil Molecular Influenza Test Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Molecular Influenza Test Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Molecular Influenza Test Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Molecular Influenza Test Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Molecular Influenza Test Revenue and Growth Rate (2015-2020)
Figure 57. UAE Molecular Influenza Test Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Molecular Influenza Test Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Molecular Influenza Test Revenue and Growth Rate (2015-2020)
Figure 60. Global Molecular Influenza Test Revenue Share by Type (2015-2020)
Figure 61. Global Molecular Influenza Test Revenue Share by Type in 2019
Figure 62. Global Molecular Influenza Test Market Share Forecast by Type (2021-2025)
Figure 63. Global RT-PCR Revenue Growth Rate (2015-2020)
Figure 64. Global TMA Revenue Growth Rate (2015-2020)
Figure 65. Global LAMP Revenue Growth Rate (2015-2020)
Figure 66. Global NASBA Revenue Growth Rate (2015-2020)
Figure 67. Global Other Revenue Growth Rate (2015-2020)
Figure 68. Global Molecular Influenza Test Revenue Share by Application (2015-2020)
Figure 69. Global Molecular Influenza Test Revenue Share by Application in 2019
Figure 70. Global Molecular Influenza Test Market Share Forecast by Application (2021-2025)
Figure 71. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 72. Global Clinical Laboratories Revenue Growth Rate (2015-2020)
Figure 73. Global Other End-User Revenue Growth Rate (2015-2020)
Figure 74. Global Molecular Influenza Test Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Molecular Influenza Test Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Molecular Influenza Test Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Molecular Influenza Test Revenue Market Forecast (2021-2025)
Figure 78. Europe Molecular Influenza Test Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Molecular Influenza Test Revenue Market Forecast (2021-2025)
Figure 80. South America Molecular Influenza Test Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Molecular Influenza Test Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel